| Title |
A phase I, open-label, single-arm, dose-escalation study of E7107, a precursor messenger ribonucleic acid (pre-mRNA) splicesome inhibitor administered intravenously on days 1 and 8 every 21 days to patients with solid tumors
|
|---|---|
| Published in |
Investigational New Drugs, November 2013
|
| DOI | 10.1007/s10637-013-0046-5 |
| Pubmed ID | |
| Authors |
D. S. Hong, R. Kurzrock, A. Naing, J. J. Wheler, G. S. Falchook, J. S. Schiffman, N. Faulkner, M. J. Pilat, J. O’Brien, P. LoRusso |
X Demographics
The data shown below were collected from the profile of 1 X user who shared this research output. Click here to find out more about how the information was compiled.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| United States | 1 | 100% |
Demographic breakdown
| Type | Count | As % |
|---|---|---|
| Scientists | 1 | 100% |
Mendeley readers
The data shown below were compiled from readership statistics for 118 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Germany | 1 | <1% |
| Unknown | 117 | 99% |
Demographic breakdown
| Readers by professional status | Count | As % |
|---|---|---|
| Student > Ph. D. Student | 35 | 30% |
| Student > Bachelor | 16 | 14% |
| Researcher | 12 | 10% |
| Student > Master | 10 | 8% |
| Other | 7 | 6% |
| Other | 13 | 11% |
| Unknown | 25 | 21% |
| Readers by discipline | Count | As % |
|---|---|---|
| Biochemistry, Genetics and Molecular Biology | 38 | 32% |
| Agricultural and Biological Sciences | 20 | 17% |
| Medicine and Dentistry | 17 | 14% |
| Chemistry | 7 | 6% |
| Pharmacology, Toxicology and Pharmaceutical Science | 5 | 4% |
| Other | 4 | 3% |
| Unknown | 27 | 23% |
Attention Score in Context
This research output has an Altmetric Attention Score of 11. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 17 January 2023.
All research outputs
#2,929,601
of 23,556,846 outputs
Outputs from Investigational New Drugs
#69
of 1,197 outputs
Outputs of similar age
#34,091
of 305,873 outputs
Outputs of similar age from Investigational New Drugs
#4
of 14 outputs
Altmetric has tracked 23,556,846 research outputs across all sources so far. Compared to these this one has done well and is in the 87th percentile: it's in the top 25% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 1,197 research outputs from this source. They receive a mean Attention Score of 4.8. This one has done particularly well, scoring higher than 94% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 305,873 tracked outputs that were published within six weeks on either side of this one in any source. This one has done well, scoring higher than 88% of its contemporaries.
We're also able to compare this research output to 14 others from the same source and published within six weeks on either side of this one. This one has gotten more attention than average, scoring higher than 71% of its contemporaries.